David Kavanagh

15PUBLICATIONS
94CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsMedical infection agents (incl. prions)Optical technologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 03, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study.

Andrew Bryant, Jan Lecouturier, Giovany Orozco-Leal

|Jun 06, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease.

Sarah McGlasson, Katy Reid, Anna Klingseisen

|Jan 31, 2025
Post-transplant Thrombotic Microangiopathy.

Anuja Java, Matthew A Sparks, David Kavanagh

|Nov 25, 2024
The role of complement factor I rare genetic variants in age related macular degeneration in Finland.

Anneliza Andreadi, Thomas M Hallam, Vicky Brocklebank

|Jun 27, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

Vicky Brocklebank, Patrick R Walsh, Kate Smith-Jackson

|Sep 08, 2022
Diagnosis and treatment of thrombotic microangiopathy.

Gemma L Thompson, David Kavanagh

Pageof 3

Frequent Collaborators

3 joint publications

David Steel

3 joint publications

Claire L Harris

2 joint publications

Emma K Montgomery

2 joint publications

Neil S Sheerin